1. Home
  2. VTGN vs AWX Comparison

VTGN vs AWX Comparison

Compare VTGN & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

N/A

Current Price

$0.17

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

AWX

Avalon Holdings Corporation

N/A

Current Price

$2.55

Market Cap

10.2M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
VTGN
AWX
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
10.2M
IPO Year
2014
1998

Fundamental Metrics

Financial Performance
Metric
VTGN
AWX
Price
$0.17
$2.55
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 751.6K
3.5K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $53,090,000.00
Revenue This Year
$33.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.14
52 Week Low
$0.17
$2.43
52 Week High
$5.14
$3.00

Technical Indicators

Market Signals
Indicator
VTGN
AWX
Relative Strength Index (RSI) 34.95 47.12
Support Level N/A $2.48
Resistance Level $0.32 $2.56
Average True Range (ATR) 0.01 0.08
MACD 0.00 -0.00
Stochastic Oscillator 5.96 23.53

Price Performance

Historical Comparison
VTGN
AWX

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment, which is the key revenue driver, provides hazardous and non-hazardous brokerage and management services to industrial, commercial, municipal, and governmental customers, captive landfill management for an industrial customer, and saltwater injection well operations. Its Golf and related operations segment consists of four golf courses and associated clubhouses, which provide dining and banquet facilities, a hotel which provides lodging and resort-related amenities.

Share on Social Networks: